Yuanbao Inc. announced a 35.6% increase in total revenues to RMB1,315.9 million and a 31.4% rise in net income to RMB387.6 million for Q1 2026, driven by growth in insurance distribution and system services. The company is advancing AI-powered insurance consultation and claims processing, enhancing user experience and operational efficiency. Yuanbao also declared an annual cash dividend of US$1.26 per ADS and authorized a US$15 million share repurchase program, reflecting strong financial health and commitment to shareholder returns. The company aims to deepen AI integration across its services to support long-term growth and industry leadership.
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
The global warehouse shuttle software market is projected to grow from $1.57 billion in 2026 to $2.66 billion by 2030, with a CAGR of 14.1%. Growth is fueled by rising e-commerce, warehouse automation, AI-driven orchestration, and robotic material ha...
